Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liver enzyme abnormalities in Parkinson's disease.

Geriatrics - 1 Aug 1991

Tanner C M

Abstract excerpt

If toxicant exposure contributes to the cause of Parkinson's disease, poor function of detoxifying enzymes could increase vulnerability for Parkinson's disease. Although no hepatic enzyme system has been shown universally to be dysfunctional in Parkinson's disease patients, several have been sugg...

Topics

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Cytochrome P-450 Enzyme System
Debrisoquin
Humans
Liver
Parkinson Disease
Phenotype

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 1894148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-1894148-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Liver enzyme abnormalities in Parkinson's disease.PMID 1894148Read ↗

Abnormal liver enzyme-mediated metabolism in Parkinson's disease: a second look.Semantic proximity Read ↗

P450 enzymes and Parkinson's disease: the story so far.Semantic proximity Read ↗

Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.Semantic proximity Read ↗

P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's disease.Semantic proximity Read ↗

Debrisoquine oxidation in Parkinson's disease.Semantic proximity Read ↗

CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.Semantic proximity Read ↗

Association between the oxidative polymorphism and early onset of Parkinson's disease.Semantic proximity Read ↗

Roles of gender, age at onset and environmental risk in the frequency of CYP2D6-deficient alleles in patients with Parkinson's disease.Semantic proximity Read ↗

Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.Semantic proximity Read ↗

Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity.Semantic proximity Read ↗

Glutathione transferase Omega class polymorphisms in Parkinson disease.Semantic proximity Read ↗

CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.